Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
FL.2.3ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
FL.2.3ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
FL.2.3NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
XBB.1.5.15ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
XBB.1.5.15ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
XBB.1.5.15ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XBB.1.5.15NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
XBB.2.3.6ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
XBB.2.3.6ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
XBB.2.3.6ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XBB.2.3.6NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
EG.2ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
EG.2ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
EG.2ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
EG.2NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
EU.1.1ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
EU.1.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
EU.1.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
EU.1.1NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
XBB.2.3.7ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
XBB.2.3.7ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
XBB.2.3.7ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XBB.2.3.7NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
FL.4.11ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
FL.4.11ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
FL.4.11ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
FL.4.11NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
BF.7.14ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-13753.9France
BF.7.14ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BF.7.14ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BF.7.14NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
XBB.1.5.59ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
XBB.1.5.59ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
XBB.1.5.59ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XBB.1.5.59NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
XBB.1.24.3ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
XBB.1.24.3ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
XBB.1.24.3ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XBB.1.24.3NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
XBB.1.17.1ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
XBB.1.17.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
XBB.1.17.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XBB.1.17.1NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
XBB.1.5.63ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
XBB.1.5.63ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
XBB.1.5.63ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XBB.1.5.63NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
FL.2.4ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
FL.2.4ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
FL.2.4ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used